ARQT earnings date and last-quarter result: last quarter beat, P/E -1453.13. Updated 2026-07-23.
Arcutis Biotherapeutics (ARQT) Research Hub
Arcutis Biotherapeutics (ARQT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 31.81 USD (+1.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1453.13, market cap 3.48B. This hub links to the full technical, earnings and options research available for ARQT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 31.81 USD (+1.96%) |
| 52-week range | 23.1 USD – 33.32 USD |
| Trend regime | Range |
| 14-day RSI | 79.6 (Overbought) |
| Trailing P/E | -1453.13 |
| Market cap | 3.48B |
| Dividend yield | 0.00% |
Available research for ARQT
Covered Call on ARQT: how it works, illustrative setup around the real 31.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARQT: how it works, illustrative setup around the real 31.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARQT: how it works, illustrative setup around the real 31.81 USD price, max profit/loss, breakeven and when to use it. Educational.
ARQT technical analysis: range, last 31.81 USD, RSI 79.6, 52w range 23.1 USD–33.32 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ARQT in?
Arcutis Biotherapeutics (ARQT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARQT in an uptrend or downtrend?
As of 2026-10-26, ARQT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARQT's trailing P/E ratio?
ARQT's trailing P/E is -1453.13, with a market cap of 3.48B. See the earnings research page for full valuation detail.